Effect of estrogen deficiency on skeletal and alveolar bone density in sheep

Journal of Periodontology

Volumn 73, Issue 4, 2002, Pages 383-391

  Johnson, R B ^a   Gilbert, J A ^a   Cooper, R C ^a   Parsell, D E ^a   Stewart, B A ^a   Dai, X ^a   Nick, T G ^a   Streckfus, C F ^a   Butler, R A ^a   Boring, J G ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Alveolar bone loss etiology; Animal studies; Biomarkers; Bone density; Bone, demineralized etiology; Estrogen deficiency adverse effects; Osteoporosis etiology; Ovariectomy adverse effects; Periodontal diseases etiology; Saliva analysis

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL; ESTROGEN; INTERLEUKIN 6; OSTEOCALCIN; PYRIDINIUM DERIVATIVE;

ALVEOLAR BONE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; BLOOD LEVEL; BONE DENSITY; BONE METABOLISM; BONE RADIOGRAPHY; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICAL BONE; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; LONGITUDINAL STUDY; MANDIBLE; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PREDICTION; RADIUS; SALIVA LEVEL; SCREENING TEST; SHEEP; SKELETON; TOOTH RADIOGRAPHY; ULNA; URINE LEVEL;

ALVEOLAR PROCESS; ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; BONE DENSITY; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGENS; FACTOR ANALYSIS, STATISTICAL; FEMALE; FOLLOW-UP STUDIES; INTERLEUKIN-6; LINEAR MODELS; LONGITUDINAL STUDIES; OSTEOCALCIN; OSTEOPOROSIS; OVARIECTOMY; PYRIDINIUM COMPOUNDS; RADIUS; RANDOM ALLOCATION; SALIVA; SHEEP; STATISTICS; STATISTICS, NONPARAMETRIC; ULNA;

EID: 0036250185     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2002.73.4.383     Document Type: Article

References (64)

1. The worldwide problem of osteoporosis: Insights afforded by epidemiology
2. The diagnosis of osteoporosis
3. Chronic destructive periodontal disease in patients with presenile osteoporosis
4. Osteoporosis and osseointegration of implants
5. Osteoporosis and periodontal disease: A review
6. Osteoporosis: A risk factor in periodontal disease
7. Tooth loss and mandibular osteopenia
8. Comparison of mandibular bone in normal and osteoporotic women
9. Postmenopausal tooth loss. Contributions to edentulism by osteoporosis and cigarette smoking
10. Relationships between mandibular and skeletal bone in an osteoporotic population
11. Region-specific bone mass changes in rat mandibular condyle following ovariectomy
12. Reduction of residual ridges: A major oral disease entity
13. Symptomatic osteoporosis: A risk factor for residual ridge reduction of the jaws
14. Osteoporosis and reduction of residual ridge in edentulous patients
15. Effect of bone mineral density in skeleton and mandible on extraction of teeth and clinical alveolar height
16. Systemic osteoporosis and oral bone loss: Evidence shows increased risk factors
17. Long-term bone mass evaluation of mandible and lumbar spine in a group of women receiving hormone replacement therapy
18. Osteoporosis and its relationship to oral bone loss
19. Osteoporosis and periodontal disease: Is there a relationship?
20. The role of osteopenia in oral bone loss and periodontal disease
21. The strength of association between systemic postmenopausal osteoporosis and periodontal disease
22. Osteoporosis and oral bone loss
23. Effect of estrogen supplementation on periodontal disease
24. The association between estrogen status and alveolar bone density changes in postmenopausal women with a history of periodontitis
25. Osteoporosis and alveolar bone loss
26. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women
27. Oral Bone loss associated with menopause
28. Associations of periodontal disease with femoral bone mineral density and estrogen replacment therapy: Cross-sectional evaluation of US adults from NHANES III
29. Mineral status of skeleton and advanced periodontal disease
30. Oral findings in osteoporosis. Part II: Relationship between residual ridge and alveolar bone resorption and generalized skeletal osteopenia
31. Periodontal status of women taking postmenopausal estrogen supplementation
32. Influence of estrogen and osteopenia/osteoporosis on clinical periodontitis in post-menopausal women
33. Comparison of alveolar bone loss, alveolar bone density, salivary and gingival crevicular fluid interleukin-6 concentrations in healthy premenopausal and postmenopausal women on estrogen therapy
34. Periodontitis in sheep: A model for human periodontal disease
35. Porphyromonas gingivalis as putative pathogen in ovine periodontitis
36. Characterization of Bacteroides from sheep periodontal disease by SDS-PAGE of outer membrane proteins
37. A longitudinal study of the cultivable subgingival anaerobic bacteria isolated from sheep during the development of broken mouth periodontitis
38. Animal Physiology: Adaptation and Environment
39. Alveolar bone loss one year following ovariectomy in sheep
40. A comparison of whole mouth resting and stimulated salivary measurement procedures
41. Reproducibility of beam alignment using different bitewing radiographic techniques
42. Alveolar bone loss as related to oral hygiene and age
43. Measurements of alveolar bone height at tooth implant abutments on intraoral radiographs
44. Effects of experimental diabetes mellitus on alveolar bone loss in periodontal disease-susceptible mice
45. Radiographic quantification of alveolar bone changes
46. A chemically modified nonantimicrobial tetracyline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats
47. Cytokines induce nitric oxide production in mouse osteoblasts
48. Black-pigmented Bacteroides associated with broken-mouth periodontitis in sheep
49. Sequential histomorphometric changes in cancellous bone from ovariohysterectomized dogs
50. Colorimetric immunoassay for native osteocalcin
51. Immunoassay for urinary pyridinoline: The new marker of bone resorption
52. New insights into the cellular, biochemical and molecular basis of post-menopausal and senile osteoporosis: Roles of IL-6 and gp 130
53. Estrogen, cytokines, and pathogenesis of post-menopausal osteoporosis
54. Role of cytokines in bone resorption
55. Interleukin 6: A cytokine for gerontologists
56. The role of interleukin-6 in certain age-related diseases
57. Chinese hamster ovarian cells transinfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leucocytosis and thrombocytosis in tumor-bearing nude mice
58. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis
59. IL-6 is produced by osteoblasts and induces bone resorption
60. Increased osteoclast development after estrogen loss: Mediation by interleukin 6
61. 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: A potential mechanism for the antiosteoporotic effect of estrogens